Lymphoma affects over 70,000 Indians annually, with approximately 40,000 new cases of Non-Hodgkin lymphoma alone, creating urgent demand for accessible, advanced treatment centers that combine clinical excellence with affordability. TL;DR Dr. Bharat Patodiya in Hyderabad provides comprehensive lymphoma treatment with CAR-T therapy evaluation, costing ₹35-45 lakhs compared to ₹3-4 crores internationally, an 80% cost reduction India now has indigenous CAR-T therapies (NexCAR19

Lymphoma patients in India now have unprecedented access to revolutionary CAR-T cell therapy, with indigenous treatments offering 70-83% response rates at costs 80% lower than international alternatives, transforming advanced blood cancer care across the country. TL;DR Dr.Bh arat Patodiya connects lymphoma patients with India's leading CAR-T centers, offering comprehensive evaluation and treatment coordination at ₹30-50 lakhs versus ₹3-4 crores internationally [1] India's in